Search research articles
Contact Us
Filters
Showing results (401-410 of 548) with videos related to
Page
of 55
Sort By:
Lancet (London, England)
|
November 25, 1989
Brain muscarinic receptors in Alzheimer's and Parkinson's diseases
K W Lange, F R Wells, M N Rossor, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 1, 1991
Cortical nicotinic receptors in Alzheimer's disease and Parkinson's disease
K W Lange, F R Wells, M N Rossor, et al.
Life Sciences
|
January 12, 1981
During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated
R G Dyer, K Murugaiah, A Theodorou, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 1, 1984
Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function
J A Pratt, P Jenner, A L Johnson, et al.
European Journal of Pharmacology
|
November 1, 1988
The D-1 dopamine receptor partial agonist, CY 208-243, exhibits antiparkinsonian activity in the MPTP-treated marmoset
J A Temlett, P N Chong, W H Oertel, et al.
British Journal of Pharmacology
|
August 1, 1988
The interaction of substituted benzamides with brain benzodiazepine binding sites in vitro
R W Horton, S Lowther, J Chivers, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
April 3, 2002
Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo
N S L Perry, P J Houghton, P Jenner, et al.
Neuropharmacology
|
June 1, 1984
Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats
K Murugaiah, S Fleminger, M D Hall, et al.
Brain : a Journal of Neurology
|
September 1, 1977
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam
D Chadwick, M Hallett, R Harris, et al.
British Journal of Pharmacology
|
December 1, 1989
Cortical muscarinic receptors in demented patients with Alzheimer's disease or Parkinson's disease
K W Lange, F R Wells, M N Rossor, et al.
Page
of 55
Search research articles
Search
Showing results (401-410 of 548) with videos related to
Sort By:
Page
of 55
Lancet (London, England)
|
November 25, 1989
Brain muscarinic receptors in Alzheimer's and Parkinson's diseases
K W Lange, F R Wells, M N Rossor, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 1, 1991
Cortical nicotinic receptors in Alzheimer's disease and Parkinson's disease
K W Lange, F R Wells, M N Rossor, et al.
Life Sciences
|
January 12, 1981
During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated
R G Dyer, K Murugaiah, A Theodorou, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 1, 1984
Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function
J A Pratt, P Jenner, A L Johnson, et al.
European Journal of Pharmacology
|
November 1, 1988
The D-1 dopamine receptor partial agonist, CY 208-243, exhibits antiparkinsonian activity in the MPTP-treated marmoset
J A Temlett, P N Chong, W H Oertel, et al.
British Journal of Pharmacology
|
August 1, 1988
The interaction of substituted benzamides with brain benzodiazepine binding sites in vitro
R W Horton, S Lowther, J Chivers, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
April 3, 2002
Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo
N S L Perry, P J Houghton, P Jenner, et al.
Neuropharmacology
|
June 1, 1984
Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats
K Murugaiah, S Fleminger, M D Hall, et al.
Brain : a Journal of Neurology
|
September 1, 1977
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam
D Chadwick, M Hallett, R Harris, et al.
British Journal of Pharmacology
|
December 1, 1989
Cortical muscarinic receptors in demented patients with Alzheimer's disease or Parkinson's disease
K W Lange, F R Wells, M N Rossor, et al.
Page
of 55